113
Participants
Start Date
December 9, 2015
Primary Completion Date
February 24, 2017
Study Completion Date
February 24, 2017
MEDI0382
MEDI0382 administered subcutaneously.
Placebo
Placebo administered subcutaneously.
Research Site, Berlin
Research Site, Lübeck
Research Site, Kiel
Research Site, Magdeburg
Research Site, Neuss
Research Site, Mainz
Research Site, Mannheim
Research Site, München
Research Site, Neu-Ulm
Research Site, Erfurt
Research Site, Leipzig
Lead Sponsor
MedImmune LLC
INDUSTRY